KZR - Kezar Life Sciences, Inc.

Kezar Life Sciences, Inc. is a United States-based clinical-stage biopharmaceutical company focused on identifying and advancing novel small molecule therapies. Its mission is to address significant unmet medical needs in both immune-mediated diseases and various forms of cancer.

Sector

Healthcare

Industry

Biotechnology

Market Cap

$53.9M

Beta

0.41

52-Week Range

3.53-7.55

CEO

Christopher J. Kirk

Employees

55

IPO Date

Jun 21, 2018

Exchange

NASDAQ

KZR Options Snapshot

Options pricing data for KZR is refreshed daily after the close. When listed contracts exist, this page surfaces the latest at-the-money implied volatility, max pain strike, dealer gamma exposure (GEX), and 25-delta skew. Listed contracts and live snapshots appear once the options chain has been published by the exchange for the most recent session.

What This Page Covers

The KZR overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.